Key facts
- This page summarizes Jonathan D. Root's Form 4 filing for Inari Medical, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Apr 2024, 16:56.
Jonathan D. Root - 24 Apr 2024 Form 4 Insider Report for Inari Medical, Inc.
- Form type
- 4
- Accepted by SEC
- 26 Apr 2024, 16:56:56 UTC
- Previous filing
- 14 Jun 2023
- Next filing
- 12 Jun 2024
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Shannon Trevino, attorney-in-fact for Jonathan Root, M.D.
SEC evidence
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan D. Root filed Form 4 for Inari Medical, Inc. on 26 Apr 2024.
Change
- Previous filing in this sequence was filed on 14 Jun 2023.
- Current net transaction value: +$174,984.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NARI
transaction
Common Stock
Award
- Transaction value
- $174,984
- Shares
- +4,126
- Change %
- +0.77%
- Price
- $42.41
- Shares after
- 541,149
- Date
- 24 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
NARI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 335
- Date
- 24 Apr 2024
- Ownership
- Directly Owned by Spouse
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents restricted stock units granted on April 24, 2024 to the Reporting Person that vest in full on the earlier of (1) the day prior to the Issuer's next annual meeting of stockholders or (2) one year from the date of grant.